Pfizer, Inc.





Market Closed - Nyse 04:00:34 2024-04-15 pm EDT After market 07:58:20 pm
25.91 USD +0.19% Intraday chart for Pfizer, Inc. 25.98 +0.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET DJ
Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... Our Logo
Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board MT
Market outlook is uncertain, but optimism prevails Our Logo
News Highlights : Top Financial Services News of the Day - Monday at 7 AM ET DJ
News Highlights : Top Financial Services News of the Day - Monday at 12 AM ET DJ
PFIZER INC : JP Morgan remains Neutral ZD
Skanska Trims Scope of Work for Biomanufacturing Facility Project in US MT
PFIZER INC : Berenberg remains Neutral ZD
Health Care Stocks Steady, Moderna Climbs -- Health Care Roundup DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading MT
Sector Update: Health Care MT
Pfizer Says Phase 3 Trial of Abrysvo for Respiratory Syncytial Virus Disease Meets Primary Endpoints MT
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access MT
Pfizer: positive results for RSV in adults CF
Pfizer's Abrysvo Hits Key Goals in Adults at Increased RSV Risk DJ
Pfizer Inc Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease CI
Pfizer RSV shot meets goals in trial of high-risk adults under age 60 RE
American Airlines, Target, Others Sue Drugmakers Over Alleged Price-Fixing MT
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period MT
North American Morning Briefing: Focus Turns to Jobs After Powell's Reassurance DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET DJ
News Highlights : Top Company News of the Day - Thursday at 3 AM ET DJ
US, Canadian companies kick off 2024 with layoffs RE
US takes next step in Medicare drug price negotiations with pharma companies RE
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
25.91 USD
Average target price
31.62 USD
Spread / Average Target
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer Receives EU Marketing Approval for Ulcerative Colitis Therapy